+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lab-on-a-Chip - Global Market Trajectory & Analytics

  • ID: 5140658
  • Report
  • April 2021
  • Region: Global
  • 140 Pages
  • Global Industry Analysts, Inc
Global Lab-on-a-Chip Market to Reach $9.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Lab-on-a-Chip estimated at US$5.1 Billion in the year 2020, is projected to reach a revised size of US$9.5 Billion by 2027, growing at a CAGR of 9.3% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 9.9% CAGR and reach US$5.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Consumables segment is readjusted to a revised 9.4% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 8.7% CAGR

The Lab-on-a-Chip market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 7.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Software & Services Segment to Record 7.2% CAGR

In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 7.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$650 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.1 Billion by the year 2027.

Select Competitors (Total 38 Featured):
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • IDEX Corporation
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
Frequently Asked Questions about the Global Market for Lab-on-a-Chip

What is the estimated value of the Global Market for Lab-on-a-Chip?

The Global Market for Lab-on-a-Chip was estimated to be valued at $5.1 Billion in 2020.

What is the growth rate of the Global Market for Lab-on-a-Chip?

The growth rate of the Global Market for Lab-on-a-Chip is 9.3%, with an estimated value of $9.5 Billion by 2027.

What is the forecasted size of the Global Market for Lab-on-a-Chip?

The Global Market for Lab-on-a-Chip is estimated to be worth $9.5 Billion by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Genomics & Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Genomics & Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 17: USA Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 18: USA 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 19: USA Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 20: USA 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • CANADA
  • Table 21: Canada Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 22: Canada 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 23: Canada Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: Canada 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • JAPAN
  • Table 25: Japan Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: Japan 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 27: Japan Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: Japan 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • CHINA
  • Table 29: China Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: China 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 31: China Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: China 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • EUROPE
  • Table 33: Europe Current & Future Analysis for Lab-on-a-Chip by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 34: Europe 7-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 35: Europe Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Europe 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 37: Europe Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Europe 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • FRANCE
  • Table 39: France Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 40: France 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 41: France Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: France 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • GERMANY
  • Table 43: Germany Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: Germany 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 45: Germany Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: Germany 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • ITALY
  • Table 47: Italy Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: Italy 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 49: Italy Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Italy 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 51: UK Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: UK 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 53: UK Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: UK 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 55: Rest of Europe Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: Rest of Europe 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 57: Rest of Europe Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: Rest of Europe 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 59: Asia-Pacific Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: Asia-Pacific 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 61: Asia-Pacific Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Asia-Pacific 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027
  • REST OF WORLD
  • Table 63: Rest of World Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Rest of World 7-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2020 & 2027
  • Table 65: Rest of World Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 66: Rest of World 7-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 38


Note: Product cover images may vary from those shown